AI should not only predict — it should heal. Healing Intelligence is ETHORITY’s philosophy and practice of building AI that restores life, trust, and planetary wellbeing. Our flagship platforms, EpiTrace.AI and BeamGuide.AI, embody this vision: one decodes the biology of life, the other translates that intelligence into real-time clinical action.
Why Healing Intelligence Matters
Ethical Imperatives
AI must heal, not just optimize
Sensitive biomedical data demands sovereignty and consent
Global crises — cancer, aging, climate — require regenerative intelligence
Strategic Enabler
EpiTrace.AI: Next-gen biomedical intelligence for cancer, aging, regenerative medicine
BeamGuide.AI: Adaptive radiotherapy guided by AI precision and ethics
Healing Intelligence = ETHORITY’s unique differentiator in the AI consulting landscape
EpiTrace.AI
What it does:
EpiTrace.AI decodes single-cell methylation and multiomics data to trace cellular lineages, identify relapse risks, and unlock regenerative medicine opportunities.
Key Features:
Lineage tracing with explainable AI
Governance-ready biomedical data integration (GDPR, EU AI Act)
Scalable platform previewed through the Gene Regulation Atlas dashboard
Governance + Healing Intelligence in Action
Challenge: Harness single-cell methylation data for cancer research, with strict GDPR & EU AI Act compliance.
Work: ETHORITY spearheaded the EpiTrace.AI initiative with DKFZ and the Dr. Rurainski Foundation, applying governance frameworks and embedding ethics into the full cycle — from Playbook → Roadmap → Development → Stable v0.9.4 release.
Outcome: A clear path to operationalize EpiTrace.AI v2x as a next-generation Biomedical Intelligence Platform, previewed in the Gene Regulation Atlas dashboard mockup. This sets the stage for integration with BeamGuide.AI, completing the Healing Intelligence loop from insight to intervention.
Platform 2: BeamGuide.AI
What it does:
BeamGuide.AI is an adaptive radiotherapy copilot. It enhances heavy-ion therapy by adjusting radiation beams in real time, aligned with tumor biology and patient movement.
Key Features:
Motion-compensated, sub-millimeter dosing accuracy
Integration with EpiTrace insights for precision medicine
Ethical AI design to protect healthy tissue and improve quality of life
Case Study: EpiTrace.AI
Challenge: Harness single-cell methylation data for cancer research under GDPR & EU AI Act compliance, with a need for ongoing monitoring of sensitive biomedical datasets.
Work: ETHORITY embedded EthiScope™ into the EpiTrace.AI initiative, orchestrating guardrail testing for bias and drift while producing Assure-ready evidence kits. The platform advanced from Playbook → Roadmap → Stable v0.9.4 release with governance and monitoring aligned.
Outcome: A governance-anchored path to operationalize EpiTrace.AI v2x as a next-generation Biomedical Intelligence Platform, previewed in the Gene Regulation Atlas dashboard — validated through ETHORITY’s Assure Certification framework.
Why ETHORITY?
20+ years of guiding Fortune 500s, DAX firms, and public institutions.
Pioneer of the AI3M Maturity Model and EAITF governance framework.
Track record in regulated sectors: healthcare, finance, public services.
Vision anchored in Healing Intelligence — AI that restores trust and drives long-term value.
AI Navigator’s Log
Written and curated by STEN, ETHORITY’s founder and AI Navigator, this log explores the frontlines of ethical and trustworthy AI. The Navigator’s Log is more than a blog — it is a strategic guide for leaders, policymakers, and innovators navigating the complexities of AI in 2030 and beyond.
